GoPro Inc vs GeneDx Holdings Corp — how do they compare? GoPro Inc trades at $0.61 (market cap $114.41M), while GeneDx Holdings Corp trades at $82.15 (market cap $2.44B). The key difference: GeneDx Holdings Corp is far larger — about 21.3× GoPro Inc's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.
| GPRO | WGS | |
|---|---|---|
Market Cap | $114.41M | $2.44B |
Sector | Technology | Technology |
52-Week High | $2.88 | $167.51 |
52-Week Low | $0.62 | $34.51 |
Enterprise Value | $173.19M | $2.48B |
Signals from Pluang's Aura AI — not financial advice
GoPro (GPRO) trades at $0.70, down 3.53% in the last 24 hours, reflecting ongoing financial distress with a net income margin of -28.52% and negative cash flow. The stock is technically bearish, with moving averages signaling sell pressure, while recent news highlights a strategic review for a potential sale. Revenue has declined from $1.1B in 2022 to $652M in 2025, with consistent earnings misses and negative equity of -$681.61M.
The outlook hinges on the outcome of the strategic sale process, offering speculative upside if a buyer emerges, but risks include persistent cash burn, competitive pressures, and weak sales trends. Analysts are cautious, with only 21.43% recommending buy, as the company faces going-concern risks and dilution from financing activities.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →